App-Quantinova.ai

Longitudinal Change in fMRI Blood Oxygen Level Dependent Signal in Cerebral Amyloid Angiopathy

Cheryl R McCreary - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Cerebral amyloid angiopathy

N/A

A Novel High-risk TIA and Minor Stroke Rapid Assessment Day-unit to Improve Quality of Care and Patient Outcomes

Jemini Abraham - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Arrhythmia

N/A

Reducing Readmissions through Secondary Stroke Prevention Clinics

Ruth Hall - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Stroke

N/A

Insights Into the Cost-effectiveness of Blood Pressure Management for Secondary Stroke Prevention

Adam G Kelly - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Dementia

Perindopril

Improving Stroke and TIA Care in the Emergency Department: Results from a Provincial Stroke Improvement Collaborative

Devin Harris - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Transient Ischemic Attack

N/A

Quality of Care and In-Hospital Outcomes by Race and Ethnicity among Patients Hospitalized with Intracerebral Hemorrhage: Findings from 123,623 Patients in the Get With The Guidelines-Stroke Program

Robert Holloway - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Intracerebral hemorrhage

Methadone hydrochloride

Anticoagulant Therapy in Head Injury-associated Cerebral Sinovenous Thrombosis in Children

Patcharee Komvilaisak - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Out of Pocket Costs for Pediatric Stroke Care

Eric Seiber - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Ischemic stroke

N/A

Efficacy of Antiplatelet Therapy for Secondary Stroke Prevention Following Lacunar Stroke: A Meta-analysis and Pooled Analysis of Randomized Controlled Trials

Chun Shing Kwok - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Ischemic stroke

Acetylsalicylic acid/Dipyridamole

Can Attenuation Characteristics on Non Contrast CT be Used in Place of Diffusion FLAIR Mismatch in the Imaging Triage of Acute Ischemic Stroke Patients?

Aakash Mahajan - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Ischemic stroke

N/A

Refinement of Imaging Predictors of Recurrent Events following Transient Ischemic Attack and Minor Stroke

Myles Horton - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Transient Ischemic Attack

N/A

Defining the Acute Infarct Core with CT Perfusion in Ischemic Stroke: Physiological and Technical Issues

Enrico Fainardi - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Ischemic stroke

N/A

Defining the Hyper-acute Infarct Core in Porcine Model of Cerebral Ischemia: A Multi-modality Imaging Study

Enrico Fainardi - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Coronary Artery Disease

endothelin-1

Collaterals in the Interventional Management of Stroke (IMS) III Trial

Thomas A Tomsick - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Ischemic stroke

N/A

Early Recanalization Rates Do Not Differ among Stroke Subtypes when Treated with Argatroban and Intravenous tPA: A Subanalysis of the Argatroban TPA Stroke Study

Waldo R Guerrero - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Ischemic stroke

Argatroban

A Novel CT-angiogram Based Recanalization Grading System (TICI-CTA) Correlates With Early Neurologic Response After Intravenous tPA Therapy

Bijoy Menon - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Stroke

N/A

Do Stroke Patients Benefit from Thrombolysis Despite Contraindications or Warnings?

James C Grotta - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Ischemic stroke

Activase I.V.

Recanalization Leads to Early Clinical Improvement in Patients Treated With Argatroban And Intravenous TPA a Subanalysis of the Argatroban Tpa Stroke Study

Andrei V Alexandrov - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Ischemic stroke

Argatroban

Characterization and outcomes of spontaneous coronary artery dissection patients presenting with an acute coronary syndrome: insights from the ACALM registry

Rahul Potluri - British Cardiovascular Society (BCS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Spontaneous coronary artery dissection

N/A

C Identification of the major genetic contributors to tetralogy of fallot

Donna J Page - British Cardiovascular Society (BCS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Cyanotic heart disease

N/A

Filters

28841 Abstracts